You're reading the free version. Trader adds the live tape and alerts.
Start tracking
STOK Sale Disclosure
Kaye Edward M. Md · SEC Form 4 · Filed Aug 18, 2026
Sale
Calculated transaction value
$381.85K
Kaye Edward M. Md Director
STOK
Stoke Therapeutics
STOK
Transaction date
Aug 18, 2026
Public filing date
Aug 18, 2026
Filing lag
Filed same day
STOK daily price context
Close on/before transaction
$32.14
Aug 18, 2026
First close after public filing
$33.03
Aug 19, 2026
30-day return after filing
-12.41%
Through Sep 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 11,930 shares @ $32.01
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001522780-26-000007
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$402.53K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Stoke Therapeutics, Inc. STOK Current | Sale | Aug 18, 2026 | $381.85K |
| Stoke Therapeutics, Inc. STOK | Sale | Aug 18, 2026 | $20.68K |
| Stoke Therapeutics, Inc. STOK | Exercise | Aug 14, 2026 | $0 |
| Stoke Therapeutics, Inc. STOK | Exercise | Aug 14, 2026 | $0 |